Summary of treatment and recommended follow-up of CML patients

Celalettin Ustun; Erica D. Warlick; Prithviraj Bose; Jerald P. Radich; John Goldman

Summary of treatment and recommended follow-up of CML patients

Celalettin Ustun, Erica D. Warlick, Prithviraj Bose, Jerald P. Radich, John Goldman

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

There are several management and monitorization guidelines for physicians treating CML. We summarize some of the important aspect of these guidelines, discuss advantages or disadvantages of commonly used TKIs, and propose a treatment algorithm. Although we are summarizing management of CML here, please refer to the prior chapters for details of CML treatment in chronic and advanced phases.

Original language	English (US)
Title of host publication	Chronic Myeloid Leukemia
Subtitle of host publication	From Daily Management to Complicated Issues
Publisher	Nova Science Publishers, Inc.
Pages	183-190
Number of pages	8
ISBN (Electronic)	9781629489926
ISBN (Print)	9781629489711
State	Published - Jan 1 2014
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Cite this

@inbook{8c6cb4d150a340a0a05f27cd67b8b8c5,

title = "Summary of treatment and recommended follow-up of CML patients",

abstract = "There are several management and monitorization guidelines for physicians treating CML. We summarize some of the important aspect of these guidelines, discuss advantages or disadvantages of commonly used TKIs, and propose a treatment algorithm. Although we are summarizing management of CML here, please refer to the prior chapters for details of CML treatment in chronic and advanced phases.",

author = "Celalettin Ustun and Warlick, {Erica D.} and Prithviraj Bose and Radich, {Jerald P.} and John Goldman",

year = "2014",

month = jan,

day = "1",

language = "English (US)",

isbn = "9781629489711",

pages = "183--190",

booktitle = "Chronic Myeloid Leukemia",

publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Summary of treatment and recommended follow-up of CML patients

AU - Ustun, Celalettin

AU - Warlick, Erica D.

AU - Bose, Prithviraj

AU - Radich, Jerald P.

AU - Goldman, John

PY - 2014/1/1

Y1 - 2014/1/1

N2 - There are several management and monitorization guidelines for physicians treating CML. We summarize some of the important aspect of these guidelines, discuss advantages or disadvantages of commonly used TKIs, and propose a treatment algorithm. Although we are summarizing management of CML here, please refer to the prior chapters for details of CML treatment in chronic and advanced phases.

AB - There are several management and monitorization guidelines for physicians treating CML. We summarize some of the important aspect of these guidelines, discuss advantages or disadvantages of commonly used TKIs, and propose a treatment algorithm. Although we are summarizing management of CML here, please refer to the prior chapters for details of CML treatment in chronic and advanced phases.

UR - http://www.scopus.com/inward/record.url?scp=84950336628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84950336628&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84950336628

SN - 9781629489711

SP - 183

EP - 190

BT - Chronic Myeloid Leukemia

PB - Nova Science Publishers, Inc.

ER -

Summary of treatment and recommended follow-up of CML patients

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this